Scientific article

[Paraneoplastic neurological syndromes: an update]

Published inRevue médicale suisse, vol. 12, no. 516, p. 832-839
Publication date2016

Paraneoplastic neurological syndromes are a group of neurological syndromes secondary to an underlying malignancy. Associated autoantibodies can be classified according to the cellular localization of the antigen target. Onconeuronal autoantibodies (targeting intracellular antigens) strongly associate with cancer and the response to immunotherapy is often disappointing. Identifying and treating the underlying malignancy is a high priority. However, immunomodulation can provide a favourable outcome for neurological symptoms associated with autoantibodies specific for cell membrane antigens. An early recognition of these disorders following the triad "clinical neurological syndrome--specific autoantibodies--tumour research" is important so that patients can benefit from appropriate targeted treatments.

  • Antigens, Neoplasm/immunology
  • Autoantibodies/immunology
  • Humans
  • Immunomodulation
  • Immunotherapy/methods
  • Neoplasms/complications/immunology
  • Paraneoplastic Syndromes, Nervous System/immunology/therapy
Citation (ISO format)
ZEKERIDOU, Anastasia et al. [Paraneoplastic neurological syndromes: an update]. In: Revue médicale suisse, 2016, vol. 12, n° 516, p. 832–839.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/30/2016 2:56:00 PM
First validation11/30/2016 2:56:00 PM
Update time03/15/2023 1:05:57 AM
Status update03/15/2023 1:05:56 AM
Last indexation01/16/2024 10:36:32 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack